AM80 | RARα agonist

AM80 chemical structure

Available Options

Size:PriceQuantity 
10 mg$50.00
50 mg$175.00
Request Quote / Bulk / Custom Size
Product Inquiry

AM80 (94497-51-5) is a  retinoic acid receptor α (RARα) agonist that induces differentiation (ED50 = 0.79 nM) and apoptosis of HL-60 cells.1 Exhibits antiproliferative effects against a variety of human tumor cells lines (mean values of 35, 40 and 60% growth inhibition at 0.1, 1 and 10 μM respectively).2  It ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17.3 AM80 induces neuronal differentiation in a human neuroblastoma NH-12 cell line.4 Pulmonary administration of AM80 regenerates collapsed alveoli.5

References/Citations:

  1. Kagechika et al. (1988), Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity; J. Med. Chem., 31 2182
  2. Jimi et al. (2007), RARalpha is a regulatory factor for Am-80-induced cell growth inhibition of hematologic malignant cells; Int. J. Oncol., 31 397
  3. Nishimori et al. (2012), Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17; Blood, 119 285
  4. Shiohira et al. (2010), Am80 induces neuronal differentiation in a human neuroblastoma NH-12 cell line; Int. J. Mol. Med., 26 393
  5. Sakai et al. (2014), Pulmonary administration of Am80 regenerates collapsed alveoli; Control. Release, 196 154
94497-51-5, AM-80, AM80, AM80 supplier, NSC608000, Retinobenzoic acid, Tamibarotene
Alternate Name:
Tamibarotene; NSC608000; Retinobenzoic acid

Safety Data Sheet:

N/A

Product Data Sheet:

Download Product Data Sheet

Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee

AM80 (94497-51-5) is a  retinoic acid receptor α (RARα) agonist that induces differentiation (ED50 = 0.79 nM) and apoptosis of HL-60 cells.1 Exhibits antiproliferative effects against a variety of human tumor cells lines (mean values of 35, 40 and 60% growth inhibition at 0.1, 1 and 10 μM respectively).2  It ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17.3 AM80 induces neuronal differentiation in a human neuroblastoma NH-12 cell line.4 Pulmonary administration of AM80 regenerates collapsed alveoli.5

References/Citations:

  1. Kagechika et al. (1988), Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity; J. Med. Chem., 31 2182
  2. Jimi et al. (2007), RARalpha is a regulatory factor for Am-80-induced cell growth inhibition of hematologic malignant cells; Int. J. Oncol., 31 397
  3. Nishimori et al. (2012), Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17; Blood, 119 285
  4. Shiohira et al. (2010), Am80 induces neuronal differentiation in a human neuroblastoma NH-12 cell line; Int. J. Mol. Med., 26 393
  5. Sakai et al. (2014), Pulmonary administration of Am80 regenerates collapsed alveoli; Control. Release, 196 154